Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Cancers|April 14, 2026
FcγRIIIA Genotype in Plasma Cell Dyscrasias Is Associated with Clinical Progression, Bone Disease Extension and Immune DysfunctionDaniela Cambria, Maria Teresa Cannizzaro, Nunziatina Laura Parrinello, et al.
Oncotarget|November 5, 2017
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)Pierpaolo Pastina, Valerio Nardone, Cirino Botta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2015
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma CellsAnnamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, et al.
Frontiers in Bioengineering and Biotechnology|March 3, 2020
Influence of the Fabrication Accuracy of Hot-Embossed PCL Scaffolds on Cell GrowthsTania Limongi, Elisabetta Dattola, Cirino Botta, et al.
Oncoimmunology|May 4, 2016
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patientsPierpaolo Correale, Cirino Botta, Elodia Claudio Martino, et al.
Molecular and Clinical Oncology|July 11, 2019
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumabRocco Giannicola, Graziella D'Arrigo, Cirino Botta, et al.
International Journal of Molecular Sciences|May 27, 2023
Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient OutcomeFederica Plano, Emilia Gigliotta, Anna Maria Corsale, et al.
Oncotarget|May 15, 2018
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccinePierpaolo Correale, Cirino Botta, Nicoletta Staropoli, et al.
Leukemia|August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myelomaDaniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Multiple Myeloma in 2023 Ways: From Trials to Real LifeManlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, et al.
Pageof 10